Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spreaded rapidly worldwide, as far as it has become a global pandemic. Therefore, the introduction of serological tests for determination of IgM and IgG antibodies has become the main diagnostic tool, useful for tracking the spread of the virus and for consequently allowing its containment. In our study we compared point of care test (POCT) lateral flow immunoassay (FIA) vs automated chemiluminescent immunoassay (CLIA), in order to assess their specificity and sensibility for COVID-19 antibodies detection.
Noce, A., Santoro, M.l., Marrone, G., D'Agostini, C., Amelio, I., Duggento, A., et al. (2020). Serological determinants of COVID-19. BIOLOGY DIRECT, 15(1), 21 [10.1186/s13062-020-00276-1].
Serological determinants of COVID-19
Noce A.;D'Agostini C.;Amelio I.;Duggento A.;Tesauro M.
;Di Daniele N.
2020-01-01
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spreaded rapidly worldwide, as far as it has become a global pandemic. Therefore, the introduction of serological tests for determination of IgM and IgG antibodies has become the main diagnostic tool, useful for tracking the spread of the virus and for consequently allowing its containment. In our study we compared point of care test (POCT) lateral flow immunoassay (FIA) vs automated chemiluminescent immunoassay (CLIA), in order to assess their specificity and sensibility for COVID-19 antibodies detection.| File | Dimensione | Formato | |
|---|---|---|---|
|
SERIOLOGICAL COVID.pdf
solo utenti autorizzati
Descrizione: FILE PDF
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
1.31 MB
Formato
Adobe PDF
|
1.31 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
